Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Pancreatic Diseases × Cefoxitin × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Pancreatic Neoplasms 1 Pancreatic Diseases 1

Interventions

Gemcitabine 2 Albumin-Bound Paclitaxel 2 130-nm albumin-bound paclitaxel 2 napabucasin 1 Piperacillin, Tazobactam Drug Combination 1 Cefoxitin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03269994 2025-10-21

Does Cefoxitin or Piperacillin-Tazobactam Prevent Postoperative Surgical Site Infections After Pancreatoduodenectomy?

Memorial Sloan Kettering Cancer Center

Phase 3 Completed

967 enrolled 9 charts

Gastrointestinal

Pancreatic Diseases, Pancreatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡